» Articles » PMID: 10835609

Efficient Generation of Midbrain and Hindbrain Neurons from Mouse Embryonic Stem Cells

Overview
Journal Nat Biotechnol
Specialty Biotechnology
Date 2000 Jun 3
PMID 10835609
Citations 326
Authors
Affiliations
Soon will be listed here.
Abstract

Embryonic stem (ES) cells are clonal cell lines derived from the inner cell mass of the developing blastocyst that can proliferate extensively in vitro and are capable of adopting all the cell fates in a developing embryo. Clinical interest in the use of ES cells has been stimulated by studies showing that isolated human cells with ES properties from the inner cell mass or developing germ cells can provide a source of somatic precursors. Previous studies have defined in vitro conditions for promoting the development of specific somatic fates, specifically, hematopoietic, mesodermal, and neurectodermal. In this study, we present a method for obtaining dopaminergic (DA) and serotonergic neurons in high yield from mouse ES cells in vitro. Furthermore, we demonstrate that the ES cells can be obtained in unlimited numbers and that these neuron types are generated efficiently. We generated CNS progenitor populations from ES cells, expanded these cells and promoted their differentiation into dopaminergic and serotonergic neurons in the presence of mitogen and specific signaling molecules. The differentiation and maturation of neuronal cells was completed after mitogen withdrawal from the growth medium. This experimental system provides a powerful tool for analyzing the molecular mechanisms controlling the functions of these neurons in vitro and in vivo, and potentially for understanding and treating neurodegenerative and psychiatric diseases.

Citing Articles

Developmental DNA demethylation is a determinant of neural stem cell identity and gliogenic competence.

MacArthur I, Ma L, Huang C, Bhavsar H, Suzuki M, Dawlaty M Sci Adv. 2024; 10(35):eado5424.

PMID: 39196941 PMC: 11352921. DOI: 10.1126/sciadv.ado5424.


Pluripotent stem cell-derived organoids: A brief history of curiosity-led discoveries.

Lancaster M Bioessays. 2024; 46(12):e2400105.

PMID: 39101295 PMC: 11589667. DOI: 10.1002/bies.202400105.


Stem cell therapies: a new era in the treatment of multiple sclerosis.

Wu L, Lu J, Lan T, Zhang D, Xu H, Kang Z Front Neurol. 2024; 15:1389697.

PMID: 38784908 PMC: 11111935. DOI: 10.3389/fneur.2024.1389697.


Challenges involved in cell therapy for Parkinson's disease using human pluripotent stem cells.

Moon H, Kim B, Kwon I, Oh Y Front Cell Dev Biol. 2023; 11:1288168.

PMID: 37886394 PMC: 10598731. DOI: 10.3389/fcell.2023.1288168.


Establishment of neural stem cells from fetal monkey brain for neurotoxicity testing.

Latham L, Dobrovolsky V, Liu S, Talpos J, Hanig J, Slikker Jr W Exp Biol Med (Maywood). 2023; 248(7):633-640.

PMID: 37208932 PMC: 10350806. DOI: 10.1177/15353702231168145.